Showing 1 - 3 results of 3 for search 'Sun Min Lim', query time: 0.01s Refine Results
  1. 1
    A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

    A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12) by Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Beung-Chul Ahn, Sung Sook Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study

    Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor a... by Enriqueta Felip, Francois Ghiringhelli, Alona Zer, Byoung Chul Cho, Sun Min Lim, Laurent Greillier, Alastair Greystoke, Nuria Pardo, Yaacov R Lawrence, Nedal Al-Sakaff, Hans-Joachim Helms, Hen Prizant, Jan Pintoffl, Farah Louise Lim

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?

    What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer? by Sun Min Lim, MD, PhD, Joo Sung Gabriel Shim, MD, Hyo Sup Shim, MD, PhD, Junko Tanizaki, MD, PhD, Jorn Nutzinger, MD, Byoung Chul Cho, MD, PhD, Ross A. Soo, MBBS, PhD

    Published 2025-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: